Rob Kelly was appointed executive vice president and president, International Operations, in January 2020. In this role, he is responsible for managing commercial operations for Zoetis in all markets outside the United States. Rob also oversees PHARMAQ, the company’s aquatic health business.

Rob most recently served as president of International Operations at Zoetis, responsible for commercial activities in international markets, excluding China and Brazil. Prior to this role, he served as senior vice president of the Asia-Pacific Cluster and senior vice president of U.S. Cattle and Equine for Zoetis. Rob has enjoyed a diverse and successful global career in Animal Health with stints at Wyeth/Fort Dodge Animal Health and Schering Plough before joining Pfizer Animal Health as part of the Wyeth acquisition.

Rob has a bachelor’s degree in Applied Science in Agriculture from the University of Western Sydney, and a master’s degree of management in Marketing from the Macquarie Graduate School of Management in Sydney.